Navigation Links
American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
Date:2/7/2008

ur business depends on contracts with the

government or its prime contractors and these contracts are impacted by

governmental priorities and are subject to potential fluctuations in

funding or early termination, including for convenience, any of which

could material adversely effect our operating results, financial

condition or cash flows.

-- We may be subject to potentially material costs and liabilities in

connection with environmental liabilities.

-- For each of our Specialty Chemicals, Fine Chemicals and Aerospace

Equipment segments, most production is conducted in a single facility

and any significant disruption or delay at a particular facility could

have a material adverse effect on our business, financial position and

results of operations.

-- The release or explosion of dangerous materials used in our business

could disrupt our operations and cause us to incur additional costs and

liability.

-- Disruptions in the supply of key raw materials and difficulties in the

supplier qualification process, as well as increases in prices of raw

materials, could adversely impact our operations.

-- Each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment

segments may be unable to comply with customer specifications and

manufacturing instructions or may experience delays or other problems

with existing or new products, which could result in increased costs,

losses of sales and potential breach of customer contracts.

-- Successful commercialization of pharmaceutical products and product

line extensions is very difficult and subject to many uncertainties.

If a customer is not able to successfully commercialize its products

for which AFC produces compounds or if the product is subsequently

recalled, then the operating results of
'/>"/>

SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
2. American Red Cross Responds to Tornadoes in the Southeast
3. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
4. Massive American Red Cross Tornado Relief Effort Spans Five States
5. Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns
6. Vitals.com Goes Red for American Heart Month
7. American Heart Month: Cracking Open Heart Health Myths
8. Consumer Reports Poll: Americans Demand Health Reform But Are Unsure About How to Achieve it
9. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
10. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
11. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
*Name:
*Comment:
*Email: